Bacterial Infections and Mycoses

318 trials 133 recruiting

Filter these 318 trials by phase, country and sponsor.

Open in Search →

Clinical impact of pharmacokinetic monitoring of antibiotics in critically ill patients Pending

2023-504480-17-00 Critical Patients admitted to the ICU 6
Pilot randomized controlled trial of the prevention of early respiratory tract infections in intubated patients. Comparison of the safety an… Pending

2025-521454-42-00 Reduced level of consciousness associated with severe t 6
Evaluation of the Pharmacokinetics of Subcutaneous Administration of Piperacillin/Tazobactam: An Open-Label, Multicentric, Non-Inferiority R… Pending

2024-519663-17-01 Infectious disease 4
Fecal microbiota transfer for the secondary prevention of recurrent urinary tract infections in premenopausal women: a phase II trial (FEMIT… Recruiting

2025-520452-28-00 Recurrent urinary tract infections (rUTI) 4 2026-05-12
Single-centre clinical trial investigating the safety and tolerability of increasing multiple doses of nebulised SS0331 in healthy participa… Recruiting

2025-523530-30-00 Treatment and post exposure prevention of respiratory t 1 2026-05-11
Phase 2 EL219 versus Liposomal Amphotericin B for Early Antifungal Therapy Recruiting

2025-522835-32-00 Suspected Invasive Mould Infection 4 2026-05-08
Adjunctive Hyperbaric Oxygen Treatment for Patients with Necrotizing Soft-Tissue Infection (HOT-NSTI trial) Recruiting

2025-521368-37-00 Necrotizing soft-tissue infection 6 2026-03-27
Chlorhexidine and/or metronidazole plus FB301 pre-treatment trial Recruiting

2025-524362-20-00 Bacterial vaginosis 4 2026-03-23
A Phase III, randomized, controlled study of furazidin for bacterial vaginosis. Recruiting

2024-515332-80-00 Bacterial vaginosis 5 2026-02-23
A phase 3 efficacy and safety study of fosmanogepix for the treatment of adult patients with invasive mold infections Recruiting

2024-516216-16-00 Invasive mold infections caused by Aspergillus spp., Fu 5 2026-02-13
How does the antibiotic cefadroxil work in treating serious Staph infections? A first look Recruiting

2025-522547-17-00 staphylococcus aureus bacteremia 4 2026-01-04
Empirical Meropenem versus Piperacillin/Tazobactam for Adult Patients with Sepsis (EMPRESS) Recruiting

2023-509703-33-00 Septic Shock 6 2025-06-26
Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants from Approximately 2 Months of Age Recruiting

2023-507600-32-00 Pneumococcal Immunization 5 2025-05-22
Impact of Albumin on Renal function in critically ill patients with Septic Shock and a high risk of Acute Kidney Injury. A Randomized Contro… Recruiting

2024-518475-58-00 Septic shock, acute kidney injury 6 2025-05-15
A study to evaluate the safety, tolerability, and pharmacokinetics of VABOMERE (meropenem-vaborbactam) in children with complicated urinary … Recruiting

2024-516360-29-00 Complicated Urinary Tract Infection (cUTI), Acute Pyel 4 2025-04-25
Evaluation of the efficacy of treatment with autovaccines vs antibiotic treatment in subjects with hip or knee prosthesis infections. Recruiting

2024-520226-10-00 Patients with hip or knee infections 5 2025-02-17
ISA-PET Recruiting

2024-515704-39-00 Invasive Aspergillosis 3 2025-01-15
Fecal transplantation to Eradicate Colonizing Emergent Superbugs Recruiting

2024-516393-29-00 Patients colonized with MDR-GNB 5 2024-12-03
Lessening Organ Dysfunction with VITamin C in septic ARDS Recruiting

2024-516394-78-00 Patient with sepsis complicated by ARDS 5 2024-11-05
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting

2023-508441-41-00 Bacteriemia producida por P. aeruginosa. 6 2024-07-08
Comparison of the efficacy of standard treatment associated with phage therapy versus standard treatment plus placebo for diabetic foot ulce… Recruiting

2022-500541-24-00 Diabetic foot 9 2024-07-02
Dexamethasone for treating severe hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype, an international … Recruiting

2023-508153-12-00 Hospital-acquired pneumonia 5 2024-03-26
Pragmatic trial on the safety and tolerability of an optimized dose of rifampicin in tuberculosis patients Recruiting

2023-509885-39-00 Tuberculosis 5 2024-01-15
Non-controlled, open-label study to evaluate tolerability, safety, and efficacy of MOB015B solution for external use in the treatment of mil… Recruiting

2024-513214-34-00 Distal Subungual Onychomycosis 4 2023-10-18